drugset / Trial / NCT00503516
Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to demonstrate the efficacy of megestrol acetate in the gain of body weight in patients with primary or mixed Dementia with a weight loss.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-12
- Completion
- 2010-02
Outcome
Outcome not reported
Stopped (Enrollment): “Difficulties to recruit the patients following the inclusion criteria”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Megestrol Acetate | Other / unclassified | 160 mg | — |